T1D
Clinical trials for T1D explained in plain language.
Never miss a new study
Get alerted when new T1D trials appear
Sign up with your email to follow new studies for T1D, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a weekly injection free people with type 1 diabetes from carb counting?
Disease control Recruiting nowThis study tests whether tirzepatide, a weekly injection already used for type 2 diabetes, can help adults with type 1 diabetes use an automated insulin pump without needing to count carbohydrates at meals. About 105 participants will be randomly assigned to receive tirzepatide o…
Matched conditions: T1D
Phase: PHASE2, PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 18, 2026 11:52 UTC
-
AI-powered family program aims to help teens with diabetes and asthma manage weight
Disease control Recruiting nowThis study tests a 3-month digital program for teens and young adults (ages 12-21) who have overweight or obesity along with type 1 diabetes or asthma. The program uses wearable devices, personalized education, and AI to support healthy habits and mental well-being. About 280 fam…
Matched conditions: T1D
Phase: NA • Sponsor: Adhera Health, Inc. • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
New drug aims to control type 1 diabetes early
Disease control Recruiting nowThis study tests a new drug, CNP-103, in people aged 12 to 35 who were diagnosed with stage 3 type 1 diabetes within the last 6 months. The goal is to see if the drug is safe and can help control the disease. Participants will receive either the drug or a placebo, and researchers…
Matched conditions: T1D
Phase: PHASE1, PHASE2 • Sponsor: COUR Pharmaceutical Development Company, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Pig cell transplant trial aims to stop severe low blood sugar in type 1 diabetes
Disease control Recruiting nowThis early-phase study tests a new treatment called OPF-310, which uses pig islet cells enclosed in a protective capsule, for people with unstable type 1 diabetes who still experience severe low blood sugar episodes despite using an automated insulin pump and continuous glucose m…
Matched conditions: T1D
Phase: PHASE1, PHASE2 • Sponsor: Otsuka Pharmaceutical Factory, Inc. • Aim: Disease control
Last updated Jun 10, 2026 13:35 UTC
-
New All-in-One diabetes device could simplify life for type 1 patients
Knowledge-focused Recruiting nowThis study is testing a new device that combines an insulin pump with a continuous glucose monitor in one unit for adults with type 1 diabetes. The goal is to see how insulin delivery near the sensor affects glucose readings and to gather data to improve the design. About 40 part…
Matched conditions: T1D
Phase: EARLY_PHASE1 • Sponsor: ClinSurge Research • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:03 UTC
-
Researchers track Insulin-Making cells in type 1 diabetes over years
Knowledge-focused Recruiting nowThis study follows people who previously took part in type 1 diabetes trials to see how long their bodies continue to produce insulin. Researchers will also look at how immune system changes relate to insulin production. The goal is to gather information that could lead to better…
Matched conditions: T1D
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC